Yoshihiko Sakata

3PUBLICATIONS
28CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 04, 2024
YAP Regulates HER3 Signaling-Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant Cancers.

Yuki Katayama, Tadaaki Yamada, Keiko Tanimura

|Dec 04, 2018
The effects of switching EGFR-TKI treatments for non-small cell lung cancer because of adverse events.

Yoshihiko Sakata, Kodai Kawamura, Naoki Shingu

Pageof 1